Cargando…
Binding and Neutralizing Capacity of Respiratory Syncytial Virus (RSV)-Specific Recombinant IgG Against RSV in Human Milk, Gastric and Intestinal Fluids from Infants
Oral administration of pathogen-specific recombinant antibodies may help to prevent infant gastrointestinal (GI) pathogen infection; however, to neutralize an infectious agent, these antibodies must resist degradation in the GI tract. Palivizumab, a recombinant antibody specific for the respiratory...
Autores principales: | Demers-Mathieu, Veronique, Lueangsakulthai, Jiraporn, Qu, Yunyao, Scottoline, Brian P., Dallas, David C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400675/ https://www.ncbi.nlm.nih.gov/pubmed/32605037 http://dx.doi.org/10.3390/nu12071904 |
Ejemplares similares
-
Survival of Recombinant Monoclonal Antibodies (IgG, IgA and sIgA) Versus Naturally-Occurring Antibodies (IgG and sIgA/IgA) in an Ex Vivo Infant Digestion Model
por: Lueangsakulthai, Jiraporn, et al.
Publicado: (2020) -
Survival of recombinant monoclonal and naturally-occurring human milk immunoglobulins A and G specific to respiratory syncytial virus F protein across simulated human infant gastrointestinal digestion
por: Lueangsakulthai, Jiraporn, et al.
Publicado: (2020) -
Purification of Antibodies From Human Milk and Infant Digestates for Viral Inhibition Assays
por: Sah, Baidya Nath P., et al.
Publicado: (2020) -
Bovine IgG Prevents Experimental Infection With RSV and Facilitates Human T Cell Responses to RSV
por: Nederend, Maaike, et al.
Publicado: (2020) -
Respiratory Syncytial Virus (RSV)
por: Walsh, Edward E., et al.
Publicado: (2015)